Zhou JJ, Luo QX, Zhang XJ, Xu XQ. Early continuous blood purification for treatment of severe acute pancreatitis: an analysis of 14 cases.
Shijie Huaren Xiaohua Zazhi 2012;
20:800-803. [DOI:
10.11569/wcjd.v20.i9.800]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the clinical efficacy of early continuous blood purification (CBP) in patients with severe acute pancreatitis (SAP).
METHODS: Fourteen patients who were diagnosed with SAP and were willing to undergo early (within 48 h after onset) CBP were included in test group, while 12 SAP patients were included in control group. All patients received mechanical ventilation, parenteral nutrition, antibiotics, vasoactive drugs, somatostatin, or anti-disseminated intravascular coagulation treatment according to indications. The test group began to receive CBP within 8 hours after the diagnosis of SAP. APACHE II score and plasma TNF-α levels were compared before treatment and 1, 3, 5 days after treatment between the two groups.
RESULTS: Early CBP significantly improved the signs and symptoms of SAP. On days 1, 3 and 5, APACHE II score and plasma TNF-α levels differed significantly between the control group and the test group (APACHE II score: 15.93 ± 4.81 vs 18.50 ± 4.77, 13.71 ± 4.01 vs 18.08 ± 4.83, 10.79 ± 2.39 vs 15.17 ± 4.59; TNF-α: 60.00 ± 15.27 vs 89.08 ± 25.56, 42.14 ± 6.94 vs 89.83 ± 23.19, 39.00 ± 6.04 vs 80.00 ± 23.02, all P < 0.05). APACHE II score and plasma TNF-α levels decreased significantly in the test group on days 1, 3 and 5 compared to before treatment (all P < 0.05).
CONCLUSION: Early CBP can significantly improve clinical symptoms, protect organ function, improve prognosis, and reduce mortality in SAP patients.
Collapse